Published in Cancer Res on December 15, 2010
HIF induces human embryonic stem cell markers in cancer cells. Cancer Res (2011) 2.46
Understanding cancer stem cell heterogeneity and plasticity. Cell Res (2012) 2.39
The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma. Cancer Cell (2014) 1.65
Reciprocal regulation of Akt and Oct4 promotes the self-renewal and survival of embryonal carcinoma cells. Mol Cell (2012) 1.63
EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer. Mol Cancer (2012) 1.63
Cancer stem cells: distinct entities or dynamically regulated phenotypes? Cancer Res (2012) 1.58
Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT-MET mechanism for optimal reprogramming. Nat Cell Biol (2013) 1.47
Molecular biology of lung cancer: clinical implications. Clin Chest Med (2011) 1.47
Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma. PLoS One (2013) 1.41
Nanog signaling in cancer promotes stem-like phenotype and immune evasion. J Clin Invest (2012) 1.37
Non-small cell lung cancer stem/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity. Cell Death Dis (2012) 1.26
Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor. Breast Cancer Res (2011) 1.24
CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer. PLoS One (2011) 1.23
Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients. Oncotarget (2014) 1.20
Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application. J Hematol Oncol (2014) 1.20
The side population in human lung cancer cell line NCI-H460 is enriched in stem-like cancer cells. PLoS One (2012) 1.16
The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. Oncogene (2013) 1.13
Expression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma. Diagn Pathol (2013) 1.12
Matrix metalloproteinase-10 is required for lung cancer stem cell maintenance, tumor initiation and metastatic potential. PLoS One (2012) 1.10
Epithelial cell adhesion molecule regulates tumor initiation and tumorigenesis via activating reprogramming factors and epithelial-mesenchymal transition gene expression in colon cancer. J Biol Chem (2012) 1.10
Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog. BMC Cancer (2014) 1.09
Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics. BMC Cancer (2011) 1.09
Nuclear β-catenin accumulation is associated with increased expression of Nanog protein and predicts poor prognosis of non-small cell lung cancer. J Transl Med (2013) 1.09
Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility. J Clin Invest (2013) 1.08
Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. Nat Rev Genet (2016) 1.07
Targeting cancer stem cells: emerging role of Nanog transcription factor. Onco Targets Ther (2013) 1.06
The network of epithelial-mesenchymal transition: potential new targets for tumor resistance. J Cancer Res Clin Oncol (2014) 1.04
Regulation of stem cell populations by microRNAs. Adv Exp Med Biol (2013) 1.04
Extracellular ATP reduces tumor sphere growth and cancer stem cell population in glioblastoma cells. Purinergic Signal (2011) 1.04
Identification of stem-like cells and clinical significance of candidate stem cell markers in gastric cancer. Oncotarget (2016) 1.02
Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary. J Ovarian Res (2012) 1.02
Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma. Oncogene (2013) 1.02
Oct4 mediates tumor initiating properties in oral squamous cell carcinomas through the regulation of epithelial-mesenchymal transition. PLoS One (2014) 1.00
MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell. BMC Cancer (2014) 0.99
DNMT-dependent suppression of microRNA regulates the induction of GBM tumor-propagating phenotype by Oct4 and Sox2. Oncogene (2014) 0.98
Inhibition of stearoyl-coA desaturase selectively eliminates tumorigenic Nanog-positive cells: improving the safety of iPS cell transplantation to myocardium. Cell Cycle (2014) 0.97
Emerging role of nanog in tumorigenesis and cancer stem cells. Int J Cancer (2014) 0.96
Dynamic equilibrium between cancer stem cells and non-stem cancer cells in human SW620 and MCF-7 cancer cell populations. Br J Cancer (2012) 0.96
Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest. Cell Death Dis (2013) 0.94
Cancer stem cells and their role in metastasis. Pharmacol Ther (2013) 0.93
Overexpression of Nodal induces a metastatic phenotype in pancreatic cancer cells via the Smad2/3 pathway. Oncotarget (2015) 0.92
Phosphorylation of Nanog is essential to regulate Bmi1 and promote tumorigenesis. Oncogene (2013) 0.91
Follicle-stimulating hormone inhibits apoptosis in ovarian cancer cells by regulating the OCT4 stem cell signaling pathway. Int J Oncol (2013) 0.91
Nanog and Oct4 overexpression increases motility and transmigration of melanoma cells. J Cancer Res Clin Oncol (2012) 0.91
Expression of Bmi1, FoxF1, Nanog, and γ-catenin in relation to hedgehog signaling pathway in human non-small-cell lung cancer. Lung (2013) 0.91
Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions. Stem Cells (2015) 0.91
Establishment of a human colorectal cancer cell line P6C with stem cell properties and resistance to chemotherapeutic drugs. Acta Pharmacol Sin (2013) 0.90
Snail contributes to the maintenance of stem cell-like phenotype cells in human pancreatic cancer. PLoS One (2014) 0.90
Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling. PLoS One (2013) 0.89
In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals. Cell Cycle (2013) 0.89
New approaches of PARP-1 inhibitors in human lung cancer cells and cancer stem-like cells by some selected anthraquinone-derived small molecules. PLoS One (2013) 0.89
Expression of seven stem-cell-associated markers in human airway biopsy specimens obtained via fiberoptic bronchoscopy. J Exp Clin Cancer Res (2013) 0.88
The implications of cancer stem cells for cancer therapy. Int J Mol Sci (2012) 0.87
Sustained activation of DNA damage response in irradiated apoptosis-resistant cells induces reversible senescence associated with mTOR downregulation and expression of stem cell markers. Cell Cycle (2014) 0.87
Regulation of embryonic stem cell pluripotency by heat shock protein 90. Stem Cells (2012) 0.87
Transitions between epithelial and mesenchymal states during cell fate conversions. Protein Cell (2014) 0.87
Cancer Stem Cell Hierarchy in Glioblastoma Multiforme. Front Surg (2016) 0.87
Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma. Oncotarget (2016) 0.86
Snail regulates Nanog status during the epithelial-mesenchymal transition via the Smad1/Akt/GSK3β signaling pathway in non-small-cell lung cancer. Oncotarget (2014) 0.86
Cellular reprogramming and hepatocellular carcinoma development. World J Gastroenterol (2013) 0.86
Proline-rich tyrosine kinase 2 and its phosphorylated form pY881 are novel prognostic markers for non-small-cell lung cancer progression and patients' overall survival. Br J Cancer (2013) 0.85
Lung cancer stem cells: Molecular features and therapeutic targets. Mol Aspects Med (2013) 0.85
EMT and stem cell-like properties associated with HIF-2α are involved in arsenite-induced transformation of human bronchial epithelial cells. PLoS One (2012) 0.85
Common stemness regulators of embryonic and cancer stem cells. World J Stem Cells (2015) 0.84
Global Oct4 target gene analysis reveals novel downstream PTEN and TNC genes required for drug-resistance and metastasis in lung cancer. Nucleic Acids Res (2015) 0.84
Redox Modulating NRF2: A Potential Mediator of Cancer Stem Cell Resistance. Oxid Med Cell Longev (2015) 0.84
A novel anticancer agent SNG1153 inhibits growth of lung cancer stem/progenitor cells. Oncotarget (2016) 0.83
The expression profile of Oct4 and Sox2 in the carcinogenesis of oral mucosa. Int J Clin Exp Pathol (2013) 0.83
Silibinin strongly inhibits the growth kinetics of colon cancer stem cell-enriched spheroids by modulating interleukin 4/6-mediated survival signals. Oncotarget (2014) 0.83
Increased expression of the pluripotency markers sex-determining region Y-box 2 and Nanog homeobox in ovarian endometriosis. Reprod Biol Endocrinol (2014) 0.83
Emerging stem cell therapies: treatment, safety, and biology. Stem Cells Int (2012) 0.83
SOX2 expression is an early event in a murine model of EGFR mutant lung cancer and promotes proliferation of a subset of EGFR mutant lung adenocarcinoma cell lines. Lung Cancer (2014) 0.83
CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistance. Oncotarget (2015) 0.83
Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53. Cell Death Dis (2015) 0.82
Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis. Int J Clin Exp Pathol (2015) 0.82
Concurrent expression of Oct4 and Nanog maintains mesenchymal stem-like property of human dental pulp cells. Int J Mol Sci (2014) 0.81
The pluripotency factor NANOG promotes the formation of squamous cell carcinomas. Sci Rep (2015) 0.81
Computational analysis of expression of human embryonic stem cell-associated signatures in tumors. BMC Res Notes (2011) 0.81
Small nucleolar RNA 78 promotes the tumorigenesis in non-small cell lung cancer. J Exp Clin Cancer Res (2015) 0.81
Transcription factors related to epithelial mesenchymal transition in tumor center and margin in invasive lung adenocarcinoma. Int J Clin Exp Pathol (2014) 0.81
Nanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W species. PLoS One (2014) 0.81
Tumour-initiating capacity is independent of epithelial-mesenchymal transition status in breast cancer cell lines. Br J Cancer (2014) 0.81
The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells. BMC Biol (2016) 0.80
Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication. J Exp Clin Cancer Res (2016) 0.80
Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transition. Int J Oncol (2014) 0.80
CD44 and CD24 coordinate the reprogramming of nasopharyngeal carcinoma cells towards a cancer stem cell phenotype through STAT3 activation. Oncotarget (2016) 0.80
The genomic stability of induced pluripotent stem cells. Protein Cell (2012) 0.80
Cancer stem-like cells can be induced through dedifferentiation under hypoxic conditions in glioma, hepatoma and lung cancer. Cell Death Discov (2017) 0.80
Nestin predicts a favorable prognosis in early ampullary adenocarcinoma and functions as a promoter of metastasis in advanced cancer. Oncol Rep (2014) 0.80
Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines. PLoS One (2016) 0.80
The prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancer. Radiol Oncol (2016) 0.79
TR4 nuclear receptor enhances prostate cancer initiation via altering the stem cell population and EMT signals in the PPARG-deleted prostate cells. Oncoscience (2015) 0.79
Regulation of NANOG in cancer cells. Mol Carcinog (2015) 0.79
Links between cancer stem cells and epithelial-mesenchymal transition. Onco Targets Ther (2015) 0.79
Establishment of mouse teratocarcinomas stem cells line and screening genes responsible for malignancy. PLoS One (2012) 0.79
An opposite effect of the CDK inhibitor, p18(INK4c) on embryonic stem cells compared with tumor and adult stem cells. PLoS One (2012) 0.79
POU5F1 enhances the invasiveness of cancer stem-like cells in lung adenocarcinoma by upregulation of MMP-2 expression. PLoS One (2013) 0.79
Ca2+/calmodulin-dependent protein kinase IIγ enhances stem-like traits and tumorigenicity of lung cancer cells. Oncotarget (2015) 0.79
The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells. Cancer Biol Ther (2016) 0.79
NANOG: a promising target for digestive malignant tumors. World J Gastroenterol (2014) 0.79
Large ventral lateral neurons modulate arousal and sleep in Drosophila. Curr Biol (2008) 2.26
Expression of axl in lung adenocarcinoma and correlation with tumor progression. Neoplasia (2005) 2.04
EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. Cancer Res (2010) 1.95
Upregulation of SOX9 in lung adenocarcinoma and its involvement in the regulation of cell growth and tumorigenicity. Clin Cancer Res (2010) 1.39
Picture archive and communication system (PACS) in the detection of fish bone: an animal study. Otolaryngol Head Neck Surg (2008) 1.38
Antitumor and antimetastatic activity of IL-23. J Immunol (2003) 1.38
Etiologic study of young ischemic stroke in Taiwan. Stroke (2002) 1.36
miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer. Cancer Res (2013) 1.31
Imaging findings of urinary tuberculosis on excretory urography and computerized tomography. J Urol (2003) 1.26
Pigment dispersing factor-dependent and -independent circadian locomotor behavioral rhythms. J Neurosci (2008) 1.26
Tumor-associated antigen L6 and the invasion of human lung cancer cells. Clin Cancer Res (2003) 1.21
CD13 (aminopeptidase N) can associate with tumor-associated antigen L6 and enhance the motility of human lung cancer cells. Int J Cancer (2005) 1.18
Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway. J Biol Chem (2002) 1.18
HCMV IE2-mediated inhibition of HAT activity downregulates p53 function. EMBO J (2004) 1.17
Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes. Clin Cancer Res (2005) 1.17
A genome-wide transgenic resource for conditional expression of Drosophila microRNAs. Development (2012) 1.16
The prevalence of restless legs syndrome in Taiwanese adults. Psychiatry Clin Neurosci (2010) 1.16
Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI. Biomaterials (2011) 1.16
Teaching neuroimages: Central variant of posterior reversible encephalopathy syndrome. Neurology (2014) 1.16
The Leptospira outer membrane protein LipL32 induces tubulointerstitial nephritis-mediated gene expression in mouse proximal tubule cells. J Am Soc Nephrol (2002) 1.15
Cited2, a coactivator of HNF4alpha, is essential for liver development. EMBO J (2007) 1.14
Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells. Mol Cancer Ther (2010) 1.11
hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing. J Clin Invest (2010) 1.11
Protein kinase C phosphorylates ribosomal protein S6 kinase betaII and regulates its subcellular localization. Mol Cell Biol (2003) 1.08
Computerized tomography characteristics that differentiate angiomyolipomas from liposarcomas in the perinephric space. J Urol (2002) 1.07
Intravitreal homocysteine-thiolactone injection leads to the degeneration of multiple retinal cells, including photoreceptors. Mol Vis (2011) 1.06
Targeting cancer stem cells: emerging role of Nanog transcription factor. Onco Targets Ther (2013) 1.06
Role of angiogenic and non-angiogenic mechanisms in oral squamous cell carcinoma: correlation with histologic differentiation and tumor progression. J Oral Pathol Med (2004) 1.06
Frequent unanticipated alleles of lethal giant larvae in Drosophila second chromosome stocks. Genetics (2009) 1.05
The emerging role of SOX2 in cell proliferation and survival and its crosstalk with oncogenic signaling in lung cancer. Stem Cells (2013) 1.05
Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells. Biomaterials (2011) 1.04
MAD2B, a novel TCF4-binding protein, modulates TCF4-mediated epithelial-mesenchymal transdifferentiation. J Biol Chem (2009) 1.03
Spinal epidural abscess successfully treated with percutaneous, computed tomography-guided, needle aspiration and parenteral antibiotic therapy: case report and review of the literature. Neurosurgery (2002) 1.03
Molecular cloning of CoA Synthase. The missing link in CoA biosynthesis. J Biol Chem (2002) 1.02
Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma. J Control Release (2012) 1.01
Cyclooxygenase-1 and bicistronic cyclooxygenase-1/prostacyclin synthase gene transfer protect against ischemic cerebral infarction. Circulation (2002) 1.00
Resveratrol induces FasL-related apoptosis through Cdc42 activation of ASK1/JNK-dependent signaling pathway in human leukemia HL-60 cells. Carcinogenesis (2004) 1.00
Oxidative-stress-related changes in the livers of bile-duct-ligated rats. J Biomed Sci (2003) 1.00
Hirayama disease. J Neurosurg Spine (2010) 0.99
Two non-homologous brain diseases-related genes, SERPINI1 and PDCD10, are tightly linked by an asymmetric bidirectional promoter in an evolutionarily conserved manner. BMC Mol Biol (2007) 0.98
Human cytomegalovirus UL76 encodes a novel virion-associated protein that is able to inhibit viral replication. J Virol (2004) 0.97
Imaging spectrum of adrenal pseudocysts on CT. Eur Radiol (2002) 0.96
Inhibition of invasion and angiogenesis by zinc-chelating agent disulfiram. Mol Pharmacol (2003) 0.96
Shortening of microsatellite deoxy(CA) repeats involved in GL331-induced down-regulation of matrix metalloproteinase-9 gene expression. Biochem Biophys Res Commun (2003) 0.94
Malignant fibrous histiocytoma presenting as hemoperitoneum mimicking hepatocellular carcinoma rupture. World J Gastroenterol (2007) 0.93
Subcellular localization and regulation of coenzyme A synthase. J Biol Chem (2003) 0.92
The investigation of mitogen-activated protein kinase phosphatase-1 as a potential pharmacological target in non-small cell lung carcinomas, assisted by non-invasive molecular imaging. BMC Cancer (2010) 0.91
Lifelong reporter gene imaging in the lungs of mice following polyethyleneimine-mediated sleeping-beauty transposon delivery. Biomaterials (2010) 0.91
Primary medulla oblongata germinoma: a case report and review of the literature. J Neurooncol (2003) 0.90
Oncostatin m modulates the mesenchymal-epithelial transition of lung adenocarcinoma cells by a mesenchymal stem cell-mediated paracrine effect. Cancer Res (2012) 0.90
The immediate early 2 protein of human cytomegalovirus (HCMV) mediates the apoptotic control in HCMV retinitis through up-regulation of the cellular FLICE-inhibitory protein expression. J Immunol (2006) 0.89
Suppression of the invasion and migration of cancer cells by SERPINB family genes and their derived peptides. Oncol Rep (2011) 0.89
Bilateral persistent trigeminal arteries with unilateral trigeminal artery to cavernous sinus fistula. A case report. Interv Neuroradiol (2013) 0.88
Spontaneous common carotid artery dissection: a case report and review of the literature. Eur Neurol (2003) 0.88
Improvement of ventilator-induced lung injury by IPS cell-derived conditioned medium via inhibition of PI3K/Akt pathway and IP-10-dependent paracrine regulation. Biomaterials (2012) 0.88
c-Myc regulates the coordinated transcription of brain disease-related PDCD10-SERPINI1 bidirectional gene pair. Mol Cell Neurosci (2009) 0.88
Promoter methylation of the hMLH1 gene and protein expression of human mutL homolog 1 and human mutS homolog 2 in resected esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg (2005) 0.87
Identification of subgroup patients with stage IIIB/IV non-small cell lung cancer at higher risk for brain metastases. Lung Cancer (2013) 0.87
Delayed gadolinium enhancement in epidural space of the cervicothoracic spine in a patient with spontaneous intracranial hypotension. Chang Gung Med J (2002) 0.87
Human kallikrein 8 protease confers a favorable clinical outcome in non-small cell lung cancer by suppressing tumor cell invasiveness. Cancer Res (2006) 0.87
Identification of prospective factors promoting osteotropism in breast cancer: a potential role for CITED2. Int J Cancer (2010) 0.87
Impact of epidermal growth factor receptor mutations on intracranial treatment response and survival after brain metastases in lung adenocarcinoma patients. Lung Cancer (2013) 0.87
Hemiballism after subthalamotomy in patients with Parkinson's disease: report of 2 cases. Mov Disord (2002) 0.87
Serial in vivo imaging of the lung metastases model and gene therapy using HSV1-tk and ganciclovir. J Nucl Med (2006) 0.86
Cadherin and catenin expression in mucoepidermoid carcinoma: correlation with histopathologic grade, clinical stage, and patient outcome. J Oral Pathol Med (2003) 0.86
Hirayama disease. Neuroimaging Clin N Am (2011) 0.85
Prediction of cerebral hyperperfusion syndrome after carotid stenting: a cerebral perfusion computed tomography study. J Comput Assist Tomogr (2009) 0.85
Suitability of computed tomography-guided biopsy specimens for subtyping and genotyping of non-small-cell lung cancer. Clin Lung Cancer (2013) 0.85
The involvement of promoter methylation and DNA methyltransferase-1 in the regulation of EpCAM expression in oral squamous cell carcinoma. Oral Oncol (2008) 0.84
Venous reflux on carotid computed tomography angiography: relationship with left-arm injection. J Comput Assist Tomogr (2007) 0.84
Nuclear localization signal-enhanced RNA interference of EZH2 and Oct4 in the eradication of head and neck squamous cell carcinoma-derived cancer stem cells. Biomaterials (2012) 0.84
Contrast material extravasation on contrast-enhanced helical computed tomographic scan of blunt abdominal trauma: its significance on the choice, time, and outcome of treatment. J Trauma (2003) 0.84
The PML isoform IV is a negative regulator of nuclear EGFR's transcriptional activity in lung cancer. Carcinogenesis (2013) 0.83
Spontaneous bilateral internal carotid artery dissection with acute stroke in young patients. Eur Neurol (2006) 0.82
DNA methyltransferase 1 expression and promoter methylation of E-cadherin in mucoepidermoid carcinoma. Cancer (2005) 0.82
Cancer-targeted BikDD gene therapy elicits protective antitumor immunity against lung cancer. Mol Cancer Ther (2011) 0.82
Aberrant expression of cell-cycle regulator cyclin D1 in breast cancer is related to chromosomal genomic instability. Genes Chromosomes Cancer (2002) 0.81
Prevalence of chronic kidney disease and prediabetes and associated risk factors: a community-based screening in Zhuhai, Southern China. Chin Med J (Engl) (2013) 0.81
Brain magnetic resonance image changes in a family with congenital and classic myotonic dystrophy. Brain Dev (2005) 0.80
MicroRNA142-3p promotes tumor-initiating and radioresistant properties in malignant pediatric brain tumors. Cell Transplant (2014) 0.80
Differential effects of two growth inhibitory K vitamin analogs on cell cycle regulating proteins in human hepatoma cells. Life Sci (2003) 0.80
Short-term effect of bilateral subthalamic stimulation for advanced Parkinson's disease. Chang Gung Med J (2003) 0.80
Extrapontine myelinolysis in a patient with systemic lupus erythematosus: a case report. J Formos Med Assoc (2002) 0.79
Dynamic upper airway changes during sleep in patients with obstructive sleep apnea syndrome. Acta Otolaryngol (2009) 0.79
Association of high body lead store with severe intracranial carotid atherosclerosis. Neurotoxicology (2009) 0.79
Carbon disulfide encephalopathy: cerebral microangiopathy. Neurotoxicology (2006) 0.79
The transcriptional activity of HERV-I LTR is negatively regulated by its cis-elements and wild type p53 tumor suppressor protein. J Biomed Sci (2006) 0.79
Reverse Lhermitte's phenomenon provoked by cervical cord compression. Acta Neurol Taiwan (2012) 0.79
Magnetic resonance imaging of extrahepatic bile duct disruption. Eur Radiol (2002) 0.78
Gender differences in carpal height ratio in a taiwanese population. J Hand Surg Am (2010) 0.78
Polyethyleneimine and DNA nanoparticles-based gene therapy for acute lung injury. Nanomedicine (2013) 0.78
A static magnetic field attenuates lipopolysaccharide-induced neuro-inflammatory response via IL-6-mediated pathway. Electromagn Biol Med (2013) 0.78
Ribose-5-phosphate isomerase A regulates hepatocarcinogenesis via PP2A and ERK signaling. Int J Cancer (2014) 0.78
Identification of a new peptide for fibrosarcoma tumor targeting and imaging in vivo. J Biomed Biotechnol (2010) 0.78